{ "cik": 1422143, "cik_padded": "0001422143", "entityName": "Kura Oncology, Inc.", "fiscal_years": [ { "accn": "0001193125-26-092567", "filed": "2026-03-05", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6638000.0, "cash": 149099000.0, "eps_diluted": -3.18, "free_cash_flow": -70696000.0, "net_income": -278666000.0, "operating_cash_flow": -64058000.0, "operating_income": -303631000.0, "revenue": 67482000.0, "stockholders_equity": 174135000.0, "total_assets": 738363000.0, "total_liabilities": 564228000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.240175725730037, "revenue_growth_yoy": 0.2523801570068482, "roa_avg2y": -0.37192113295633966, "roa_period_end": -0.3774105690561418, "roe_avg2y": -0.9482063714856875, "roe_period_end": -1.6002871335458122 } }, { "accn": "0001193125-26-092567", "filed": "2026-03-05", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 472000.0, "cash": 224462000.0, "eps_diluted": -2.02, "free_cash_flow": 133845000.0, "net_income": -173983000.0, "operating_cash_flow": 134317000.0, "operating_income": -193195000.0, "revenue": 53883000.0, "stockholders_equity": 413640000.0, "total_assets": 760159000.0, "total_liabilities": 346519000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8377308770911904, "roa_avg2y": -0.2877906928658979, "roa_period_end": -0.2288771164979958, "roe_avg2y": -0.4291039852610576, "roe_period_end": -0.42061454404796433 } }, { "accn": "0001193125-26-092567", "filed": "2026-03-05", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 168000.0, "cash": 37318000.0, "eps_diluted": -2.08, "free_cash_flow": -124992000.0, "net_income": -152631000.0, "operating_cash_flow": -124824000.0, "operating_income": -165804000.0, "stockholders_equity": 397273000.0, "total_assets": 448935000.0, "total_liabilities": 51662000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.130041558323873, "roa_avg2y": -0.33721627721236663, "roa_period_end": -0.3399846302916904, "roe_avg2y": -0.3733858805138762, "roe_period_end": -0.3841967614209876 } }, { "accn": "0001193125-26-092567", "filed": "2026-03-05", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 626000.0, "cash": 51802000.0, "eps_diluted": -2.03, "free_cash_flow": -110688000.0, "net_income": -135840000.0, "operating_cash_flow": -110062000.0, "operating_income": -139865000.0, "stockholders_equity": 420278000.0, "total_assets": 456306000.0, "total_liabilities": 36028000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08572421111740325, "roa_avg2y": -0.2743253190516147, "roa_period_end": -0.29769496785052135, "roe_avg2y": -0.2931101633748235, "roe_period_end": -0.323214634123128 } }, { "accn": "0000950170-25-029975", "filed": "2025-02-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1147000.0, "cash": 90672000.0, "eps_diluted": -1.97, "free_cash_flow": -105698000.0, "net_income": -130466000.0, "operating_cash_flow": -104551000.0, "stockholders_equity": 506609000.0, "total_assets": 534051000.0, "total_liabilities": 27442000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05416800727977592, "roa_avg2y": -0.2208923838298499, "roa_period_end": -0.24429502051302215, "roe_avg2y": -0.23349327167265913, "roe_period_end": -0.25752799496258455 } }, { "accn": "0000950170-24-021094", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2171000.0, "cash": 325493000.0, "eps_diluted": -1.69, "free_cash_flow": -72001000.0, "net_income": -89625000.0, "operating_cash_flow": -69830000.0, "stockholders_equity": 610905000.0, "total_assets": 647212000.0, "total_liabilities": 36307000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05943149916926527, "roa_avg2y": -0.20158932234498148, "roa_period_end": -0.13847858197932053, "roe_avg2y": -0.21604558833100715, "roe_period_end": -0.14670857170918555 } }, { "accn": "0001564590-21-007822", "filed": "2023-02-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 26135000.0, "net_income": -63140000.0, "operating_cash_flow": -54760000.0, "stockholders_equity": 218781000.0, "total_assets": 241972000.0, "total_liabilities": 23191000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10600097814709687, "roa_avg2y": -0.29758383979300157, "roa_period_end": -0.26093928223100193, "roe_avg2y": -0.3325205521294692, "roe_period_end": -0.2885991013844895 } }, { "accn": "0001564590-21-007822", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 16119000.0, "net_income": -60447000.0, "operating_cash_flow": -48655000.0, "stockholders_equity": 160985000.0, "total_assets": 182379000.0, "total_liabilities": 21394000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.13289436904059385, "roa_avg2y": -0.4345110160658448, "roa_period_end": -0.3314361850870988, "roe_avg2y": -0.5019472700851152, "roe_period_end": -0.3754821877814703 } }, { "accn": "0001564590-21-007822", "filed": "2021-02-24", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 11433000.0, "net_income": -35434000.0, "operating_cash_flow": -28441000.0, "stockholders_equity": 79865000.0, "total_assets": 95851000.0, "total_liabilities": 15986000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.20016277468227633, "roa_avg2y": -0.4277608769134193, "roa_period_end": -0.3696779376323669, "roe_avg2y": -0.5182644561616486, "roe_period_end": -0.44367369936768297 } }, { "accn": "0001564590-20-006391", "filed": "2020-02-25", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 9725000.0, "net_income": -27560000.0, "stockholders_equity": 56876000.0, "total_assets": 69821000.0, "total_liabilities": 12945000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2276003938392292, "roa_period_end": -0.39472365047765, "roe_period_end": -0.48456290878402136 } }, { "accn": "0001564590-17-004291", "filed": "2017-03-14", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "capex": "USD" }, "fundamentals": { "capex": 64000.0 }, "period_end": "2015-12-31", "ratios": {} }, { "accn": "0001213900-15-001429", "filed": "2015-02-27", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "operating_cash_flow": "USD", "operating_income": "USD" }, "fundamentals": { "operating_cash_flow": -15955.0, "operating_income": -23907.0 }, "period_end": "2014-12-31", "ratios": {} }, { "accn": "0001213900-15-001429", "filed": "2015-02-27", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "operating_income": "USD" }, "fundamentals": { "operating_income": -22734.0 }, "period_end": "2013-12-31", "ratios": {} }, { "accn": "0001213900-14-001896", "filed": "2014-03-31", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "operating_income": "USD" }, "fundamentals": { "operating_income": -22341.0 }, "period_end": "2012-12-31", "ratios": {} }, { "accn": "0001144204-13-018035", "filed": "2013-03-28", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "operating_income": "USD" }, "fundamentals": { "operating_income": -23440.0 }, "period_end": "2011-12-31", "ratios": {} }, { "accn": "0001144204-12-018805", "filed": "2012-03-30", "fiscal_year": 2010, "form": "10-K", "fundamental_units": { "operating_income": "USD" }, "fundamentals": { "operating_income": -20509.0 }, "period_end": "2010-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-092567", "filed": "2026-03-05", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001422143.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001422143.json" }, "ticker": "KURA" }